BI 661051

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 661051, covering 2013-10-31 to 2013-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Single Rising Dose Study to Assess Safety, Tolerability and Pharmacokinetics of BI 661051. [Phase 1]